2022
DOI: 10.36416/1806-3756/e20220056
|View full text |Cite
|
Sign up to set email alerts
|

Tuberculosis: a deadly and neglected disease in the COVID-19 era

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
3

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 4 publications
0
5
0
3
Order By: Relevance
“…It should be remembered that COVID-19 had a major impact on TB treatment, as it caused additional challenges beyond epidemiological surveillance, at the national and international levels, and in the recognition of the need for public policies aimed at reducing inequalities in access to systems health and the urgent reduction of social injustice ( 18 ) .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…It should be remembered that COVID-19 had a major impact on TB treatment, as it caused additional challenges beyond epidemiological surveillance, at the national and international levels, and in the recognition of the need for public policies aimed at reducing inequalities in access to systems health and the urgent reduction of social injustice ( 18 ) .…”
Section: Discussionmentioning
confidence: 99%
“…According to Maciel et al . ( 18 ) , COVID-19 and TB are different diseases, with different impacts on public health, establishing different government actions to combat them, without correct investments for control and innovation for both diseases. In Brazil, funding for TB did not reach 0.1% of the total amount allocated to science and technology in all areas at the time of the pandemic.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…(1) This scenario becomes even more complex and worrying when we consider that tuberculosis disproportionately affects underdeveloped and developing countries and the most socioeconomic vulnerable groups. (2) Regarding this context, WHO launched the "End Tuberculosis Strategy", an international proposal that aims to eliminate the global tuberculosis epidemic. (3) This strategy is anchored in pillars of research and innovation, support systems, and integrated patientcentered care and prevention.…”
Section: Introductionmentioning
confidence: 99%
“…De acordo com Maciel et al (2022), a COVID-19 e a tuberculose são doenças diferentes, com impactos distintos na saúde pública, estabelecendo ações diferenciadas dos governos; todavia, sem investimentos corretos, a inovação para o controle de qualquer doença continua bastante limitada. No Brasil, o financiamento para a TB não atingiu 0,1% do valor total alocado para a ciência e tecnologia em todas as áreas na época da pandemia.…”
Section: De Acordo Comunclassified